Kaleo · 3 days ago
Senior Specialist, Regulatory Affairs
Kaléo is a company that has secured multiple contracts with the U.S. government for the production of new medical countermeasures. The Senior Regulatory Affairs Specialist will manage and execute the overall Regulatory Affairs programs necessary to achieve and maintain regulatory approval for Kaleo's products, working across a spectrum of regulatory issues for both drug and device regulations.
BiotechnologyHealth CareMedical
Responsibilities
Develops and implements regulatory strategies to facilitate the progress of programs in all phases of development
Prepare annual reports, supplements, amendments, and change notifications to regulatory agencies and ensure periodic reports are submitted to regulatory dossiers
Participate with team members in drafting and submitting dossiers in different regions around the world, including Chemistry, Manufacturing, and Controls (CMC); nonclinical; human factors; clinical; and pharmacovigilance activities
Assist in drafting and reviewing product labeling
Review clinical and non-clinical study protocols and other documentation, and assess clinical study related changes to determine regulatory impact
Review human factors study protocols and other human factors documentation
Support regulatory audits, as required
Assist in developing and maintaining Regulatory Affairs department procedures
Qualification
Required
A bachelor's degree in a scientific discipline or equivalent combination of education and experience
At least 5 years of laboratory, regulatory, or quality experience in the pharmaceutical, biotechnology, or medical device industries
Specialist knowledge in US Regulatory Affairs and industry best practices
Proficiency with Electronic Common Technical Document (eCTD) software
Proficiency with Microsoft Office Suite
Proficiency with Adobe Acrobat
Experience submitting to regulatory agencies, including NDAs
Preferred
Experience with combination products (drug / device) preferred
Regulatory Affairs Certification (RAC) strongly preferred
Company
Kaleo
kaleo is a pharmaceutical company that develops combination drug products that empowers patients to control their medical conditions.
Funding
Current Stage
Growth StageTotal Funding
$165MKey Investors
PDL Biopharma
2021-11-29Acquired
2014-04-07Debt Financing· $150M
2012-05-29Debt Financing· $15M
Recent News
Iceland Review Online
2025-11-04
2025-11-03
Company data provided by crunchbase